Global Recombinant Erythropoietin Drugs Supply, Demand and Key Producers, 2023-2029

Description

Erythropoietin (EPO), also known as haematopoietin or haemopoietin, is a glycoprotein cytokine secreted by the kidney in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. Low levels of EPO (around 10 mU/mL) are constantly secreted sufficient to compensate for normal red blood cell turnover. Common causes of cellular hypoxia resulting in elevated levels of EPO (up to 10 000 mU/mL) include any anemia, and hypoxemia due to chronic lung disease.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. Liver production predominates in the fetal and perinatal period; renal production predominates in adulthood. It is homologous with thrombopoietin.

This report studies the global Recombinant Erythropoietin Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Erythropoietin Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Erythropoietin Drugs that contribute to its increasing demand across many markets.

The global Recombinant Erythropoietin Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Recombinant Erythropoietin Drugs total production and demand, 2018-2029, (KG)
Global Recombinant Erythropoietin Drugs total production value, 2018-2029, (USD Million)
Global Recombinant Erythropoietin Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (KG)
Global Recombinant Erythropoietin Drugs consumption by region & country, CAGR, 2018-2029 & (KG)
U.S. VS China: Recombinant Erythropoietin Drugs domestic production, consumption, key domestic manufacturers and share
Global Recombinant Erythropoietin Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (KG)
Global Recombinant Erythropoietin Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (KG)
Global Recombinant Erythropoietin Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (KG)
This reports profiles key players in the global Recombinant Erythropoietin Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Roche, 3SBio Group, Celltrion, Inc, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd and LG Life Sciences Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Erythropoietin Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (KG) and average price (USD/g) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Erythropoietin Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Recombinant Erythropoietin Drugs Market, Segmentation by Type
    rhEPO
    Erythropoiesis-Stimulating Agents (ESA)

Global Recombinant Erythropoietin Drugs Market, Segmentation by Application
    Chronic Kidney Disease
    Cancer Related Anemia
    Others

Companies Profiled:
    Amgen
    Johnson & Johnson
    Kyowa Hakko Kirin
    Roche
    3SBio Group
    Celltrion, Inc
    Teva Pharmaceutical Industries Ltd
    F. Hoffmann-La Roche Ltd
    LG Life Sciences Ltd
    Biocon Limited
    Intas Pharmaceuticals Ltd
    Sun Pharmaceutical Industries Ltd
    Dr. Reddy's Laboratories Ltd

Key Questions Answered
1. How big is the global Recombinant Erythropoietin Drugs market?
2. What is the demand of the global Recombinant Erythropoietin Drugs market?
3. What is the year over year growth of the global Recombinant Erythropoietin Drugs market?
4. What is the production and production value of the global Recombinant Erythropoietin Drugs market?
5. Who are the key producers in the global Recombinant Erythropoietin Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Recombinant Erythropoietin Drugs Introduction
    1.2 World Recombinant Erythropoietin Drugs Supply & Forecast
        1.2.1 World Recombinant Erythropoietin Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Recombinant Erythropoietin Drugs Production (2018-2029)
        1.2.3 World Recombinant Erythropoietin Drugs Pricing Trends (2018-2029)
    1.3 World Recombinant Erythropoietin Drugs Production by Region (Based on Production Site)
        1.3.1 World Recombinant Erythropoietin Drugs Production Value by Region (2018-2029)
        1.3.2 World Recombinant Erythropoietin Drugs Production by Region (2018-2029)
        1.3.3 World Recombinant Erythropoietin Drugs Average Price by Region (2018-2029)
        1.3.4 North America Recombinant Erythropoietin Drugs Production (2018-2029)
        1.3.5 Europe Recombinant Erythropoietin Drugs Production (2018-2029)
        1.3.6 China Recombinant Erythropoietin Drugs Production (2018-2029)
        1.3.7 Japan Recombinant Erythropoietin Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Recombinant Erythropoietin Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Recombinant Erythropoietin Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Recombinant Erythropoietin Drugs Demand (2018-2029)
    2.2 World Recombinant Erythropoietin Drugs Consumption by Region
        2.2.1 World Recombinant Erythropoietin Drugs Consumption by Region (2018-2023)
        2.2.2 World Recombinant Erythropoietin Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Recombinant Erythropoietin Drugs Consumption (2018-2029)
    2.4 China Recombinant Erythropoietin Drugs Consumption (2018-2029)
    2.5 Europe Recombinant Erythropoietin Drugs Consumption (2018-2029)
    2.6 Japan Recombinant Erythropoietin Drugs Consumption (2018-2029)
    2.7 South Korea Recombinant Erythropoietin Drugs Consumption (2018-2029)
    2.8 ASEAN Recombinant Erythropoietin Drugs Consumption (2018-2029)
    2.9 India Recombinant Erythropoietin Drugs Consumption (2018-2029)

3 World Recombinant Erythropoietin Drugs Manufacturers Competitive Analysis
    3.1 World Recombinant Erythropoietin Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Recombinant Erythropoietin Drugs Production by Manufacturer (2018-2023)
    3.3 World Recombinant Erythropoietin Drugs Average Price by Manufacturer (2018-2023)
    3.4 Recombinant Erythropoietin Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Recombinant Erythropoietin Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Recombinant Erythropoietin Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Recombinant Erythropoietin Drugs in 2022
    3.6 Recombinant Erythropoietin Drugs Market: Overall Company Footprint Analysis
        3.6.1 Recombinant Erythropoietin Drugs Market: Region Footprint
        3.6.2 Recombinant Erythropoietin Drugs Market: Company Product Type Footprint
        3.6.3 Recombinant Erythropoietin Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Recombinant Erythropoietin Drugs Production Value Comparison
        4.1.1 United States VS China: Recombinant Erythropoietin Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Recombinant Erythropoietin Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Recombinant Erythropoietin Drugs Production Comparison
        4.2.1 United States VS China: Recombinant Erythropoietin Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Recombinant Erythropoietin Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Recombinant Erythropoietin Drugs Consumption Comparison
        4.3.1 United States VS China: Recombinant Erythropoietin Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Recombinant Erythropoietin Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Recombinant Erythropoietin Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Recombinant Erythropoietin Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Recombinant Erythropoietin Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Recombinant Erythropoietin Drugs Production (2018-2023)
    4.5 China Based Recombinant Erythropoietin Drugs Manufacturers and Market Share
        4.5.1 China Based Recombinant Erythropoietin Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Recombinant Erythropoietin Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Recombinant Erythropoietin Drugs Production (2018-2023)
    4.6 Rest of World Based Recombinant Erythropoietin Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Recombinant Erythropoietin Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Recombinant Erythropoietin Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Recombinant Erythropoietin Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Recombinant Erythropoietin Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 rhEPO
        5.2.2 Erythropoiesis-Stimulating Agents (ESA)
    5.3 Market Segment by Type
        5.3.1 World Recombinant Erythropoietin Drugs Production by Type (2018-2029)
        5.3.2 World Recombinant Erythropoietin Drugs Production Value by Type (2018-2029)
        5.3.3 World Recombinant Erythropoietin Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Recombinant Erythropoietin Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Chronic Kidney Disease
        6.2.2 Cancer Related Anemia
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Recombinant Erythropoietin Drugs Production by Application (2018-2029)
        6.3.2 World Recombinant Erythropoietin Drugs Production Value by Application (2018-2029)
        6.3.3 World Recombinant Erythropoietin Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Recombinant Erythropoietin Drugs Product and Services
        7.1.4 Amgen Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Details
        7.2.2 Johnson & Johnson Major Business
        7.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Product and Services
        7.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Johnson & Johnson Recent Developments/Updates
        7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.3 Kyowa Hakko Kirin
        7.3.1 Kyowa Hakko Kirin Details
        7.3.2 Kyowa Hakko Kirin Major Business
        7.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product and Services
        7.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Kyowa Hakko Kirin Recent Developments/Updates
        7.3.6 Kyowa Hakko Kirin Competitive Strengths & Weaknesses
    7.4 Roche
        7.4.1 Roche Details
        7.4.2 Roche Major Business
        7.4.3 Roche Recombinant Erythropoietin Drugs Product and Services
        7.4.4 Roche Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Roche Recent Developments/Updates
        7.4.6 Roche Competitive Strengths & Weaknesses
    7.5 3SBio Group
        7.5.1 3SBio Group Details
        7.5.2 3SBio Group Major Business
        7.5.3 3SBio Group Recombinant Erythropoietin Drugs Product and Services
        7.5.4 3SBio Group Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 3SBio Group Recent Developments/Updates
        7.5.6 3SBio Group Competitive Strengths & Weaknesses
    7.6 Celltrion, Inc
        7.6.1 Celltrion, Inc Details
        7.6.2 Celltrion, Inc Major Business
        7.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Product and Services
        7.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Celltrion, Inc Recent Developments/Updates
        7.6.6 Celltrion, Inc Competitive Strengths & Weaknesses
    7.7 Teva Pharmaceutical Industries Ltd
        7.7.1 Teva Pharmaceutical Industries Ltd Details
        7.7.2 Teva Pharmaceutical Industries Ltd Major Business
        7.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
        7.7.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
        7.7.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
    7.8 F. Hoffmann-La Roche Ltd
        7.8.1 F. Hoffmann-La Roche Ltd Details
        7.8.2 F. Hoffmann-La Roche Ltd Major Business
        7.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product and Services
        7.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
        7.8.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
    7.9 LG Life Sciences Ltd
        7.9.1 LG Life Sciences Ltd Details
        7.9.2 LG Life Sciences Ltd Major Business
        7.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product and Services
        7.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 LG Life Sciences Ltd Recent Developments/Updates
        7.9.6 LG Life Sciences Ltd Competitive Strengths & Weaknesses
    7.10 Biocon Limited
        7.10.1 Biocon Limited Details
        7.10.2 Biocon Limited Major Business
        7.10.3 Biocon Limited Recombinant Erythropoietin Drugs Product and Services
        7.10.4 Biocon Limited Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Biocon Limited Recent Developments/Updates
        7.10.6 Biocon Limited Competitive Strengths & Weaknesses
    7.11 Intas Pharmaceuticals Ltd
        7.11.1 Intas Pharmaceuticals Ltd Details
        7.11.2 Intas Pharmaceuticals Ltd Major Business
        7.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product and Services
        7.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Intas Pharmaceuticals Ltd Recent Developments/Updates
        7.11.6 Intas Pharmaceuticals Ltd Competitive Strengths & Weaknesses
    7.12 Sun Pharmaceutical Industries Ltd
        7.12.1 Sun Pharmaceutical Industries Ltd Details
        7.12.2 Sun Pharmaceutical Industries Ltd Major Business
        7.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
        7.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
        7.12.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
    7.13 Dr. Reddy's Laboratories Ltd
        7.13.1 Dr. Reddy's Laboratories Ltd Details
        7.13.2 Dr. Reddy's Laboratories Ltd Major Business
        7.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product and Services
        7.13.4 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Dr. Reddy's Laboratories Ltd Recent Developments/Updates
        7.13.6 Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Recombinant Erythropoietin Drugs Industry Chain
    8.2 Recombinant Erythropoietin Drugs Upstream Analysis
        8.2.1 Recombinant Erythropoietin Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Recombinant Erythropoietin Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Recombinant Erythropoietin Drugs Production Mode
    8.6 Recombinant Erythropoietin Drugs Procurement Model
    8.7 Recombinant Erythropoietin Drugs Industry Sales Model and Sales Channels
        8.7.1 Recombinant Erythropoietin Drugs Sales Model
        8.7.2 Recombinant Erythropoietin Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Recombinant Erythropoietin Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Recombinant Erythropoietin Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Recombinant Erythropoietin Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Recombinant Erythropoietin Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Recombinant Erythropoietin Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Recombinant Erythropoietin Drugs Production by Region (2018-2023) & (KG)
    Table 7. World Recombinant Erythropoietin Drugs Production by Region (2024-2029) & (KG)
    Table 8. World Recombinant Erythropoietin Drugs Production Market Share by Region (2018-2023)
    Table 9. World Recombinant Erythropoietin Drugs Production Market Share by Region (2024-2029)
    Table 10. World Recombinant Erythropoietin Drugs Average Price by Region (2018-2023) & (USD/g)
    Table 11. World Recombinant Erythropoietin Drugs Average Price by Region (2024-2029) & (USD/g)
    Table 12. Recombinant Erythropoietin Drugs Major Market Trends
    Table 13. World Recombinant Erythropoietin Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (KG)
    Table 14. World Recombinant Erythropoietin Drugs Consumption by Region (2018-2023) & (KG)
    Table 15. World Recombinant Erythropoietin Drugs Consumption Forecast by Region (2024-2029) & (KG)
    Table 16. World Recombinant Erythropoietin Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Recombinant Erythropoietin Drugs Producers in 2022
    Table 18. World Recombinant Erythropoietin Drugs Production by Manufacturer (2018-2023) & (KG)
    Table 19. Production Market Share of Key Recombinant Erythropoietin Drugs Producers in 2022
    Table 20. World Recombinant Erythropoietin Drugs Average Price by Manufacturer (2018-2023) & (USD/g)
    Table 21. Global Recombinant Erythropoietin Drugs Company Evaluation Quadrant
    Table 22. World Recombinant Erythropoietin Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Recombinant Erythropoietin Drugs Production Site of Key Manufacturer
    Table 24. Recombinant Erythropoietin Drugs Market: Company Product Type Footprint
    Table 25. Recombinant Erythropoietin Drugs Market: Company Product Application Footprint
    Table 26. Recombinant Erythropoietin Drugs Competitive Factors
    Table 27. Recombinant Erythropoietin Drugs New Entrant and Capacity Expansion Plans
    Table 28. Recombinant Erythropoietin Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Recombinant Erythropoietin Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Recombinant Erythropoietin Drugs Production Comparison, (2018 & 2022 & 2029) & (KG)
    Table 31. United States VS China Recombinant Erythropoietin Drugs Consumption Comparison, (2018 & 2022 & 2029) & (KG)
    Table 32. United States Based Recombinant Erythropoietin Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Recombinant Erythropoietin Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Recombinant Erythropoietin Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Recombinant Erythropoietin Drugs Production (2018-2023) & (KG)
    Table 36. United States Based Manufacturers Recombinant Erythropoietin Drugs Production Market Share (2018-2023)
    Table 37. China Based Recombinant Erythropoietin Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Recombinant Erythropoietin Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Recombinant Erythropoietin Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Recombinant Erythropoietin Drugs Production (2018-2023) & (KG)
    Table 41. China Based Manufacturers Recombinant Erythropoietin Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Recombinant Erythropoietin Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Recombinant Erythropoietin Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Recombinant Erythropoietin Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Recombinant Erythropoietin Drugs Production (2018-2023) & (KG)
    Table 46. Rest of World Based Manufacturers Recombinant Erythropoietin Drugs Production Market Share (2018-2023)
    Table 47. World Recombinant Erythropoietin Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Recombinant Erythropoietin Drugs Production by Type (2018-2023) & (KG)
    Table 49. World Recombinant Erythropoietin Drugs Production by Type (2024-2029) & (KG)
    Table 50. World Recombinant Erythropoietin Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Recombinant Erythropoietin Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Recombinant Erythropoietin Drugs Average Price by Type (2018-2023) & (USD/g)
    Table 53. World Recombinant Erythropoietin Drugs Average Price by Type (2024-2029) & (USD/g)
    Table 54. World Recombinant Erythropoietin Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Recombinant Erythropoietin Drugs Production by Application (2018-2023) & (KG)
    Table 56. World Recombinant Erythropoietin Drugs Production by Application (2024-2029) & (KG)
    Table 57. World Recombinant Erythropoietin Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Recombinant Erythropoietin Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Recombinant Erythropoietin Drugs Average Price by Application (2018-2023) & (USD/g)
    Table 60. World Recombinant Erythropoietin Drugs Average Price by Application (2024-2029) & (USD/g)
    Table 61. Amgen Basic Information, Manufacturing Base and Competitors
    Table 62. Amgen Major Business
    Table 63. Amgen Recombinant Erythropoietin Drugs Product and Services
    Table 64. Amgen Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Amgen Recent Developments/Updates
    Table 66. Amgen Competitive Strengths & Weaknesses
    Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 68. Johnson & Johnson Major Business
    Table 69. Johnson & Johnson Recombinant Erythropoietin Drugs Product and Services
    Table 70. Johnson & Johnson Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Johnson & Johnson Recent Developments/Updates
    Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 73. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
    Table 74. Kyowa Hakko Kirin Major Business
    Table 75. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product and Services
    Table 76. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Kyowa Hakko Kirin Recent Developments/Updates
    Table 78. Kyowa Hakko Kirin Competitive Strengths & Weaknesses
    Table 79. Roche Basic Information, Manufacturing Base and Competitors
    Table 80. Roche Major Business
    Table 81. Roche Recombinant Erythropoietin Drugs Product and Services
    Table 82. Roche Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Roche Recent Developments/Updates
    Table 84. Roche Competitive Strengths & Weaknesses
    Table 85. 3SBio Group Basic Information, Manufacturing Base and Competitors
    Table 86. 3SBio Group Major Business
    Table 87. 3SBio Group Recombinant Erythropoietin Drugs Product and Services
    Table 88. 3SBio Group Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. 3SBio Group Recent Developments/Updates
    Table 90. 3SBio Group Competitive Strengths & Weaknesses
    Table 91. Celltrion, Inc Basic Information, Manufacturing Base and Competitors
    Table 92. Celltrion, Inc Major Business
    Table 93. Celltrion, Inc Recombinant Erythropoietin Drugs Product and Services
    Table 94. Celltrion, Inc Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Celltrion, Inc Recent Developments/Updates
    Table 96. Celltrion, Inc Competitive Strengths & Weaknesses
    Table 97. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
    Table 98. Teva Pharmaceutical Industries Ltd Major Business
    Table 99. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
    Table 100. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
    Table 102. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
    Table 103. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
    Table 104. F. Hoffmann-La Roche Ltd Major Business
    Table 105. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product and Services
    Table 106. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. F. Hoffmann-La Roche Ltd Recent Developments/Updates
    Table 108. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
    Table 109. LG Life Sciences Ltd Basic Information, Manufacturing Base and Competitors
    Table 110. LG Life Sciences Ltd Major Business
    Table 111. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product and Services
    Table 112. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. LG Life Sciences Ltd Recent Developments/Updates
    Table 114. LG Life Sciences Ltd Competitive Strengths & Weaknesses
    Table 115. Biocon Limited Basic Information, Manufacturing Base and Competitors
    Table 116. Biocon Limited Major Business
    Table 117. Biocon Limited Recombinant Erythropoietin Drugs Product and Services
    Table 118. Biocon Limited Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Biocon Limited Recent Developments/Updates
    Table 120. Biocon Limited Competitive Strengths & Weaknesses
    Table 121. Intas Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
    Table 122. Intas Pharmaceuticals Ltd Major Business
    Table 123. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product and Services
    Table 124. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Intas Pharmaceuticals Ltd Recent Developments/Updates
    Table 126. Intas Pharmaceuticals Ltd Competitive Strengths & Weaknesses
    Table 127. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
    Table 128. Sun Pharmaceutical Industries Ltd Major Business
    Table 129. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product and Services
    Table 130. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
    Table 132. Dr. Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
    Table 133. Dr. Reddy's Laboratories Ltd Major Business
    Table 134. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product and Services
    Table 135. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Production (KG), Price (USD/g), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 136. Global Key Players of Recombinant Erythropoietin Drugs Upstream (Raw Materials)
    Table 137. Recombinant Erythropoietin Drugs Typical Customers
    Table 138. Recombinant Erythropoietin Drugs Typical Distributors
List of Figure
    Figure 1. Recombinant Erythropoietin Drugs Picture
    Figure 2. World Recombinant Erythropoietin Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Recombinant Erythropoietin Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Recombinant Erythropoietin Drugs Production (2018-2029) & (KG)
    Figure 5. World Recombinant Erythropoietin Drugs Average Price (2018-2029) & (USD/g)
    Figure 6. World Recombinant Erythropoietin Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Recombinant Erythropoietin Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Recombinant Erythropoietin Drugs Production (2018-2029) & (KG)
    Figure 9. Europe Recombinant Erythropoietin Drugs Production (2018-2029) & (KG)
    Figure 10. China Recombinant Erythropoietin Drugs Production (2018-2029) & (KG)
    Figure 11. Japan Recombinant Erythropoietin Drugs Production (2018-2029) & (KG)
    Figure 12. Recombinant Erythropoietin Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 15. World Recombinant Erythropoietin Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 17. China Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 18. Europe Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 19. Japan Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 20. South Korea Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 21. ASEAN Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 22. India Recombinant Erythropoietin Drugs Consumption (2018-2029) & (KG)
    Figure 23. Producer Shipments of Recombinant Erythropoietin Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Erythropoietin Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Erythropoietin Drugs Markets in 2022
    Figure 26. United States VS China: Recombinant Erythropoietin Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Recombinant Erythropoietin Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Recombinant Erythropoietin Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Recombinant Erythropoietin Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Recombinant Erythropoietin Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Recombinant Erythropoietin Drugs Production Market Share 2022
    Figure 32. World Recombinant Erythropoietin Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Recombinant Erythropoietin Drugs Production Value Market Share by Type in 2022
    Figure 34. rhEPO
    Figure 35. Erythropoiesis-Stimulating Agents (ESA)
    Figure 36. World Recombinant Erythropoietin Drugs Production Market Share by Type (2018-2029)
    Figure 37. World Recombinant Erythropoietin Drugs Production Value Market Share by Type (2018-2029)
    Figure 38. World Recombinant Erythropoietin Drugs Average Price by Type (2018-2029) & (USD/g)
    Figure 39. World Recombinant Erythropoietin Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Recombinant Erythropoietin Drugs Production Value Market Share by Application in 2022
    Figure 41. Chronic Kidney Disease
    Figure 42. Cancer Related Anemia
    Figure 43. Others
    Figure 44. World Recombinant Erythropoietin Drugs Production Market Share by Application (2018-2029)
    Figure 45. World Recombinant Erythropoietin Drugs Production Value Market Share by Application (2018-2029)
    Figure 46. World Recombinant Erythropoietin Drugs Average Price by Application (2018-2029) & (USD/g)
    Figure 47. Recombinant Erythropoietin Drugs Industry Chain
    Figure 48. Recombinant Erythropoietin Drugs Procurement Model
    Figure 49. Recombinant Erythropoietin Drugs Sales Model
    Figure 50. Recombinant Erythropoietin Drugs Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source